Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-007452
Filing Date
2012-07-26
Accepted
2012-07-26 14:02:23
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2210280z10-q.htm 10-Q 354295
2 EX-31.1 a2210280zex-31_1.htm EX-31.1 14833
3 EX-32.1 a2210280zex-32_1.htm EX-32.1 7465
10 G604248.JPG g604248.jpg GRAPHIC 16072
  Complete submission text file 0001047469-12-007452.txt   3059613

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20120630.xml EX-101.INS 309340
5 EX-101.SCH nutr-20120630.xsd EX-101.SCH 28265
6 EX-101.CAL nutr-20120630_cal.xml EX-101.CAL 64513
7 EX-101.DEF nutr-20120630_def.xml EX-101.DEF 139285
8 EX-101.LAB nutr-20120630_lab.xml EX-101.LAB 472355
9 EX-101.PRE nutr-20120630_pre.xml EX-101.PRE 228846
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

EIN.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 12986963
SIC: 2833 Medicinal Chemicals & Botanical Products